Detection of extended spetrum β-lactamase production in clinical isolates of Klebsiella spp

Indian Journal of Medical Research

Volumn 127, Issue 4, 2008, Pages 344-346

  Jain, Amita ^a   Mondal, Rajesh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cefpodoxime; ESBL; Klebsiella spp.; Neonatal septicaemia

Indexed keywords

AZTREONAM; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFTIZOXIME; DRUG DERIVATIVE;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME ANALYSIS; ENZYME SYNTHESIS; HUMAN; INDIA; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEPTICEMIA; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROBACTER INFECTION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; SEPSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTIZOXIME; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE, NEONATAL; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 51349114205     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sturenburg E, Mack D. Extended spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J infect 2003; 47: 273-95.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th Informational Supplement; Wayne, Pennsylvania. CLSI Document M100-S16; 2006.
3. MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV-derived extended spectrum beta-lactamase detection. Clin Microbial Infect 2002; 8: 715-24.
4. Ho PL, Tsang DN, Ho M, Yuen KY. Comparison of screening methods for detection of extended spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. APIMS 2000; 108: 237-40.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 13th Informational Supplement. Wayne, Pennsylvania. CLSI Document M100-S13: 2003.
6. Bauer AW, Kirby WMM, Sherris JC, Tuck M. Antibiotics susceptibility testing by standardized single disc method. Am J Clin Pathol 1966; 45: 493-6
7. M. Zali FH, Chanawong A, Kerr KG, Birkenead D, Hawkey PM. Detection of extended spectrum beta-lactamases in members of the family enterobacteriacae: comparison of the MAST DD test, the double disc and the E test EBL. J. Antimicrob Chemother 2000; 45: 881-5.
8. Mathai D, Lewis MT, Kugler KC, Pfalloer MA, Jones RN. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the SENTRY antimicrobial surveillance programme (North America, 1998). Diagn Microbiol Infect Dis 2001; 39: 105-16.
9. Bradford PA. Extended spectrum beta lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
10. Bedenic B, Beader N, Zagar Z. Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing extended spectrum beta-lactamases. Clin Microbiol Infect 2001; 7: 626-5.
11. Thomson KS, Moland ES. Cefepime, piperacillin-tazobactem, and the inoculum effect in tests with extended spectrum beta-lactamases producing Enterobacteriaceae. Antimicrob Agents Chemother 2001; 45: 3548-54.
12. Fantin B, Pangon B, Potel G. Activity of sulbactem in combination with ceftriaxone in vitro and in experimental endocarditis caused by E coli producing SHV-2- like beta lacamase. Antimicrob Agents Chemother 1990: 34: 581-6.
13. Rice LB, Yao JD, Kliim K, Eliopoulus GM, Modeling Jr. RC. Efficacy of different beta lacatmases against an extended spectrum beta-lactamases-producing Klebsiella pneumoniae strain in the rat intra-abdominal abcesses model. Antimicrob Agents Chemother 1991; 35: 1243-4.
14. Paterson DL, Robert AB. Extend d spectrum beta-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-86.
15. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended spectrum beta-lactamases. J Clin Microbiol 1994; 32: 691-6.
16. Gibb AP, Crichton M. Cefpodoxime screening of E. coli and Klebsiella spp. by Vitek for detection of organisms producing extended spectrum beta-lactamases. Diagn Microbiol Infect Dis 2000; 382: 55-7.